MEDIWOUND LTD (MDWD) Stock Price, Quote, News and Overview
NASDAQ:MDWD - Nasdaq - IL0011316309 - Common Stock - Currency: USD
MDWD Quote, Performance and Key Statistics
20.34
+0.45 (+2.26%)
The current stock price of MDWD is 20.34 USD. In the past month the price increased by 12.81%. In the past year, price increased by 24.1%.
MDWD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 51.98 | 678.00B | ||
| JNJ | JOHNSON & JOHNSON | 15.19 | 367.19B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 19.48 | 302.61B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.54 | 222.20B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.8 | 216.87B | ||
| MRK | MERCK & CO. INC. | 9.99 | 195.88B | ||
| PFE | PFIZER INC | 7.18 | 130.67B | ||
| SNY | SANOFI-ADR | 13.67 | 128.55B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.41 | 95.71B | ||
| GSK | GSK PLC-SPON ADR | 7.06 | 78.75B | ||
| ZTS | ZOETIS INC | 26.91 | 72.25B | ||
| HLN | HALEON PLC-ADR | 22.57 | 49.87B |
Related stock screener links
About MDWD
Company Profile
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. ; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.
Company Info
MEDIWOUND LTD
42 Hayarkon Street
YAVNE 8122745 IL
CEO: Sharon Malka
Employees: 111
Phone: 972779714100
MEDIWOUND LTD / MDWD FAQ
What is the stock price of MEDIWOUND LTD today?
The current stock price of MDWD is 20.34 USD. The price increased by 2.26% in the last trading session.
What is the ticker symbol for MEDIWOUND LTD stock?
The exchange symbol of MEDIWOUND LTD is MDWD and it is listed on the Nasdaq exchange.
On which exchange is MDWD stock listed?
MDWD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MEDIWOUND LTD stock?
11 analysts have analysed MDWD and the average price target is 30.6 USD. This implies a price increase of 50.44% is expected in the next year compared to the current price of 20.34. Check the MEDIWOUND LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MEDIWOUND LTD worth?
MEDIWOUND LTD (MDWD) has a market capitalization of 219.88M USD. This makes MDWD a Micro Cap stock.
How many employees does MEDIWOUND LTD have?
MEDIWOUND LTD (MDWD) currently has 111 employees.
What are the support and resistance levels for MEDIWOUND LTD (MDWD) stock?
MEDIWOUND LTD (MDWD) has a support level at 19.89. Check the full technical report for a detailed analysis of MDWD support and resistance levels.
Is MEDIWOUND LTD (MDWD) expected to grow?
The Revenue of MEDIWOUND LTD (MDWD) is expected to grow by 20.91% in the next year. Check the estimates tab for more information on the MDWD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MEDIWOUND LTD (MDWD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MDWD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MDWD, evaluating the profitability, health, valuation and growth aspects
- MEDIWOUND LTD (MDWD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDIWOUND LTD (MDWD) Sales and EPS estimates to see what analysts future expectations are.
- MEDIWOUND LTD (MDWD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDIWOUND LTD (MDWD) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDIWOUND LTD (MDWD) Stock Chart to make your own analysis
- MEDIWOUND LTD (MDWD) Latest news and press-releases to stay up to date.
Does MEDIWOUND LTD (MDWD) stock pay dividends?
MDWD does not pay a dividend.
When does MEDIWOUND LTD (MDWD) report earnings?
MEDIWOUND LTD (MDWD) will report earnings on 2025-08-12.
What is the Price/Earnings (PE) ratio of MEDIWOUND LTD (MDWD)?
MEDIWOUND LTD (MDWD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.09).
What is the Short Interest ratio of MEDIWOUND LTD (MDWD) stock?
The outstanding short interest for MEDIWOUND LTD (MDWD) is 12.77% of its float. Check the ownership tab for more information on the MDWD short interest.
MDWD Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MDWD. When comparing the yearly performance of all stocks, MDWD is one of the better performing stocks in the market, outperforming 89.25% of all stocks.
MDWD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MDWD. MDWD may be in some trouble as it scores bad on both profitability and health.
MDWD Financial Highlights
Over the last trailing twelve months MDWD reported a non-GAAP Earnings per Share(EPS) of -2.09. The EPS decreased by -51.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -41.12% | ||
| ROE | -97.02% | ||
| Debt/Equity | 0.21 |
MDWD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to MDWD. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 5.31% and a revenue growth 20.91% for MDWD